Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06146218 · ClinicalTrials.gov registry record · NA

Compassion-Based Resiliency Training (CBRT) Intervention on Racism-based Stress

A NA study, sponsored by Rockefeller University.

Completed
Registry status
NA
Development phase
22
Enrollment target

NCT06146218: Completed NA study, sponsored by Rockefeller University.

NCT06146218 is a NA study that has completed, run by Rockefeller University. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06146218, a NA study, has completed, sponsored by Rockefeller University.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target

Study Summary

The primary aim of this study is to explore the feasibility, acceptability, and preliminary effectiveness of CBRT intervention among African Americans compared to a wait-list control group. The specific objectives include assessing feasibility, gathering participant feedback, evaluating CBRT's impact on psychological and biological outcomes, and exploring the mediating role of mindfulness. The study is a 1-group pretest-posttest design. 20 African American participants will be recruited from various sources and undergo baseline and follow-up assessments. The intervention involves a 10-week CBRT program focusing on mindfulness, compassion, self-awareness, and stress-reduction techniques. Measures include sociodemographics and psychological measures (race-based stress, depression, perceived stress, quality of life, social connectedness, sleep, and resilience) and biological measures ( allostatic load, saliva cortisol, telomere length, and gene expression. Data is collected at baseline and 10 weeks.

Primary Outcome

number of participants who complete the study

Interventions

  • BEHAVIORAL Contemplative-Based Resilience Training (CBRT)

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2024-02-15
Est. Completion 2024-08-09
Phase NA
Rockefeller University

117 total trials

What the finished NCT06146218 record still lists

NCT06146218 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Contemplative-Based Resilience Training (CBRT) is the first listed.

NCT06146218 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06146218 about?

NCT06146218 is a clinical study titled "Compassion-Based Resiliency Training (CBRT) Intervention on Racism-based Stress". The primary aim of this study is to explore the feasibility, acceptability, and preliminary effectiveness of CBRT intervention among African Americans compared to a wait-list control group. The specific objectives include assessing feasibility, gathering participant feedback, evaluating CBRT's impac...

What is the current status of trial NCT06146218?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2024-02-15. Estimated completion is 2024-08-09.

What interventions are being tested in trial NCT06146218?

The interventions under investigation include: Contemplative-Based Resilience Training (CBRT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06146218?

This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06146218's enrollment target sits among peer trials

22 1756th of 2000 higher than 239 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06146218, the US trial registry maintained by the National Library of Medicine. NCT06146218 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.